Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhigh voltage-gated calcium channel activity

CACNA1C CACNA1D CACNA1S

5.98e-05141123GO:0008331
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

ATRX TWNK CHD1 CHD2 MSH3 ALKBH3 DKC1 DNMT1

1.16e-042621128GO:0140097
GeneOntologyMolecularFunctionATP-dependent activity

ATRX MYO7A TWNK CHD1 CHD2 MSH3 DNAH7 ATP10D ATP11B HSPA4 HSPA6 HSP90AA1

1.72e-0461411212GO:0140657
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity involved in cardiac muscle cell action potential

CACNA1C CACNA1D

3.08e-0451122GO:0086007
GeneOntologyCellularComponentI band

CACNA1C CACNA1D CACNA1S SPTAN1 GRIN2B DST PRKD1

2.81e-051661107GO:0031674
GeneOntologyCellularComponentL-type voltage-gated calcium channel complex

CACNA1C CACNA1D CACNA1S

3.01e-05121103GO:1990454
GeneOntologyCellularComponentsarcomere

CACNA1C CACNA1D CACNA1S MYOM1 SPTAN1 GRIN2B DST PRKD1

5.21e-052491108GO:0030017
GeneOntologyCellularComponentT-tubule

CACNA1C CACNA1D CACNA1S SCN2A FER1L5

6.09e-05791105GO:0030315
GeneOntologyCellularComponentsarcolemma

CACNA1C CACNA1D CACNA1S DST SCN2A GNAS FER1L5

6.63e-051901107GO:0042383
GeneOntologyCellularComponentmyofibril

CACNA1C CACNA1D CACNA1S MYOM1 SPTAN1 GRIN2B DST PRKD1

9.91e-052731108GO:0030016
GeneOntologyCellularComponentZ disc

CACNA1C CACNA1D SPTAN1 GRIN2B DST PRKD1

1.48e-041511106GO:0030018
GeneOntologyCellularComponentcontractile muscle fiber

CACNA1C CACNA1D CACNA1S MYOM1 SPTAN1 GRIN2B DST PRKD1

1.50e-042901108GO:0043292
GeneOntologyCellularComponentinner dynein arm

DNAI3 DNAH7

1.20e-03101102GO:0036156
GeneOntologyCellularComponentnuclear pore cytoplasmic filaments

RANBP2 NUP98

1.20e-03101102GO:0044614
MousePhenoabnormal temporal memory

CDC14C CACNA1C ATRX KALRN GRIN2B CDC14B RNF103 TET1 C3 HSPA4

2.76e-062398910MP:0001468
MousePhenoabnormal DNA repair

CDC14C CHD2 MSH3 CDC14B TET1 DKC1 MYBL1

1.87e-05130897MP:0008058
MousePhenoabnormal contextual conditioning behavior

CDC14C CACNA1C ATRX KALRN CDC14B RNF103 C3 HSPA4

4.77e-05205898MP:0001469
DomainVDCC_L_a1su

CACNA1C CACNA1D CACNA1S

7.49e-0741083IPR005446
DomainCa_chan_IQ

CACNA1C CACNA1D CACNA1S

6.47e-0671083SM01062
DomainCa_chan_IQ

CACNA1C CACNA1D CACNA1S

6.47e-0671083PF08763
DomainVDCC_a1su_IQ

CACNA1C CACNA1D CACNA1S

6.47e-0671083IPR014873
DomainGPHH

CACNA1C CACNA1D CACNA1S

6.47e-0671083PF16905
DomainGPHH_dom

CACNA1C CACNA1D CACNA1S

6.47e-0671083IPR031649
DomainSpectrin

TRIO KALRN SPTAN1 DST

8.60e-06231084PF00435
DomainVDCCAlpha1

CACNA1C CACNA1D CACNA1S

2.19e-05101083IPR002077
DomainSpectrin_repeat

TRIO KALRN SPTAN1 DST

2.25e-05291084IPR002017
DomainSPEC

TRIO KALRN SPTAN1 DST

3.36e-05321084SM00150
DomainSpectrin/alpha-actinin

TRIO KALRN SPTAN1 DST

3.36e-05321084IPR018159
DomainDUF4208

CHD1 CHD2

9.90e-0531082PF13907
DomainCAC1F_C

CACNA1C CACNA1D

9.90e-0531082IPR031688
DomainDUF4208

CHD1 CHD2

9.90e-0531082IPR025260
DomainCAC1F_C

CACNA1C CACNA1D

9.90e-0531082PF16885
DomainDUF4208

CHD1 CHD2

9.90e-0531082SM01176
DomainEF-hand-dom_pair

CACNA1C CACNA1S CALU SPTAN1 SPOCK2 CAPN11 DST LPCAT2

2.63e-042871088IPR011992
DomainChannel_four-helix_dom

CACNA1C CACNA1D CACNA1S SCN2A

3.30e-04571084IPR027359
Domain-

CACNA1C CACNA1D CACNA1S SCN2A

3.30e-045710841.20.120.350
DomainEF_Hand_1_Ca_BS

CALU SPTAN1 DNAH7 CAPN11 DST LPCAT2

5.40e-041751086IPR018247
DomainSNF2_N

ATRX CHD1 CHD2

8.25e-04321083IPR000330
DomainSNF2_N

ATRX CHD1 CHD2

8.25e-04321083PF00176
Domain-

RANBP2 RPAP3 RMDN3 MTOR EMC2 PRPF39

1.29e-0320710861.25.40.10
DomainZF_CXXC

TET1 DNMT1

1.76e-03111082PS51058
DomainZnf_CXXC

TET1 DNMT1

1.76e-03111082IPR002857
Domainzf-CXXC

TET1 DNMT1

1.76e-03111082PF02008
DomainEF-hand_1

CALU SPTAN1 CAPN11 DST LPCAT2

1.90e-031521085PF00036
Domain-

HSPA4 HSPA6

2.11e-031210822.60.34.10
DomainHSP70_peptide-bd

HSPA4 HSPA6

2.11e-03121082IPR029047
DomainEFh

CALU SPTAN1 CAPN11 DST LPCAT2

2.25e-031581085SM00054
DomainEF_hand_dom

CALU SPTAN1 DNAH7 CAPN11 DST LPCAT2

2.30e-032321086IPR002048
DomainTPR-like_helical_dom

RANBP2 RPAP3 RMDN3 MTOR EMC2 PRPF39

2.35e-032331086IPR011990
Domain-

HSPA4 HSPA6

2.48e-031310821.20.1270.10
DomainHeat_shock_70_CS

HSPA4 HSPA6

2.48e-03131082IPR018181
DomainHSP70_C

HSPA4 HSPA6

2.48e-03131082IPR029048
DomainP_typ_ATPase_c

ATP10D ATP11B

2.88e-03141082IPR032630
DomainP-type_ATPase_N

ATP10D ATP11B

2.88e-03141082IPR032631
DomainP-type_ATPase_IV

ATP10D ATP11B

2.88e-03141082IPR006539
DomainPhoLip_ATPase_C

ATP10D ATP11B

2.88e-03141082PF16212
DomainPhoLip_ATPase_N

ATP10D ATP11B

2.88e-03141082PF16209
DomainPept_M10A_Zn_BS

MMP10 MMP15

3.31e-03151082IPR021158
DomainAcyltransferase

AGPAT4 LPCAT2

3.77e-03161082PF01553
DomainHSP70

HSPA4 HSPA6

3.77e-03161082PF00012
Domain-

CALU SPTAN1 SPOCK2 CAPN11 DST LPCAT2

4.10e-0326110861.10.238.10
DomainKinase-like_dom

SLK TRIO KALRN CAMK1 DST MTOR DSTYK PRKD1 MAPK10

4.20e-035421089IPR011009
DomainPlsC

AGPAT4 LPCAT2

4.26e-03171082SM00563
DomainHSP70_2

HSPA4 HSPA6

4.26e-03171082PS00329
DomainHemopexin_CS

MMP10 MMP15

4.26e-03171082IPR018486
DomainPlipid/glycerol_acylTrfase

AGPAT4 LPCAT2

4.26e-03171082IPR002123
DomainHSP70_1

HSPA4 HSPA6

4.26e-03171082PS00297
DomainHSP70_3

HSPA4 HSPA6

4.26e-03171082PS01036
DomainIon_trans_dom

CACNA1C CACNA1D CACNA1S SCN2A

4.33e-031141084IPR005821
DomainIon_trans

CACNA1C CACNA1D CACNA1S SCN2A

4.33e-031141084PF00520
DomainSer/Thr_kinase_AS

SLK TRIO KALRN CAMK1 DSTYK PRKD1 MAPK10

4.71e-033571087IPR008271
DomainPept_M10A_stromelysin-type

MMP10 MMP15

4.77e-03181082IPR016293
DomainChromodomain_CS

CHD1 CHD2

4.77e-03181082IPR023779
DomainHsp_70_fam

HSPA4 HSPA6

4.77e-03181082IPR013126
DomainS_TKc

SLK TRIO KALRN CAMK1 DSTYK PRKD1 MAPK10

4.86e-033591087SM00220
DomainPROTEIN_KINASE_ST

SLK TRIO KALRN CAMK1 DSTYK PRKD1 MAPK10

5.08e-033621087PS00108
PathwayKEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1C CACNA1D CACNA1S

4.33e-066863M47762
PathwayKEGG_TYPE_II_DIABETES_MELLITUS

CACNA1C CACNA1D PIK3R3 MTOR MAPK10

9.42e-0647865M19708
PathwayWP_CALCIUM_REGULATION_IN_CARDIAC_CELLS

CACNA1C CACNA1D CACNA1S CAMK1 GJB5 PRKD1 GNAS

3.14e-05147867MM15854
PathwayREACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS

RANBP2 NUP98 MTOR HSPA4 HSPA6 HSP90AA1

3.45e-05101866M27253
PathwayWP_CALCIUM_REGULATION_IN_CARDIAC_CELLS

CACNA1C CACNA1D CACNA1S CAMK1 GJB5 PRKD1 GNAS

3.73e-05151867M39329
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004

CACNA1C CACNA1D CACNA1S

7.60e-0514863M47692
PathwayWP_ALZHEIMERS_DISEASE

CACNA1C CACNA1D CACNA1S PIK3R3 PSMD7 GRIN2B MTOR MAPK10

1.89e-04261868M42565
PathwayWP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER

CACNA1C PIK3R3 GRIN2B MTOR

2.40e-0450864M39822
PathwayREACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS

RANBP2 NUP98 MTOR HSPA4 HSP90AA1

2.44e-0492865MM14951
PathwayREACTOME_RHO_GTPASE_CYCLE

SLK TRIO KALRN SPTAN1 PIK3R3 PLEKHG5 DST NHS DEPDC1B HSP90AA1

3.31e-044398610MM15595
PathwayKEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1C CACNA1D CACNA1S

3.55e-0423863M47666
PathwayKEGG_GNRH_SIGNALING_PATHWAY

CACNA1C CACNA1D CACNA1S GNAS MAPK10

3.76e-04101865M1979
PathwayREACTOME_RHO_GTPASE_CYCLE

SLK TRIO KALRN SPTAN1 PIK3R3 PLEKHG5 DST NHS DEPDC1B HSP90AA1

4.02e-044508610M27078
PathwayKEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL

CACNA1C CACNA1D CACNA1S

4.58e-0425863M47948
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

EHBP1 RANBP2 SLK ATRX RTCB RPAP3 PARG NUP98 CHD1 PSMD7 ESF1 SCML2 DST DKC1 HSPA4 PRRC2A DEPDC1B HSP90AA1 DNMT1

1.86e-109341131933916271
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

EHBP1 TRIO RTCB CALU SPTAN1 PSMD7 DNAH7 DST MTOR DSTYK TET1 ZNF286B RBM7 NHS GNAS DEPDC1B CEP170B DNMT1

3.82e-108611131836931259
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CRIM1 HLA-A ATRX TRIO KALRN SPTAN1 RBP4 SPOCK2 PSMD7 MSH3 CAMK1 GRIN2B USP9Y GFAP DST OSBPL1A PRRC2A TARS1 ZMYM4 HSP90AA1 DNMT1

9.73e-1012851132135914814
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

RANBP2 SLK HLA-A ATRX TRIO RTCB CALU SPTAN1 NUP98 KRI1 CHD1 PSMD7 MSH3 ESF1 MTOR DKC1 GNAS EMC2 HSPA4 THRAP3 TARS1 DNMT1

1.05e-0914251132230948266
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

RANBP2 HLA-A TRIO RPAP3 CALU SPTAN1 PIK3R3 NUP98 KRI1 PSMD7 CDC14B CLCC1 ESF1 SSH1 NHS PRRC2A HSPA6 HSP90AA1 DNMT1

1.27e-0910491131927880917
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

RANBP2 ATRX SPTAN1 PARG NUP98 ESF1 STRIP1 SCML2 SSH1 RBM7 DKC1 PRRC2A CCDC9 THRAP3 ZMYM4 DNMT1

4.63e-097741131615302935
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

RANBP2 ATRX SPTAN1 GRIN2B ELFN2 GFAP DKC1 PRRC2A THRAP3 CEP170B

4.70e-092311131016452087
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

RANBP2 SLK TRIO KALRN SPTAN1 GRIN2B STRIP1 SLC7A3 DST SSH1 MTOR PRKD1 PRRC2A THRAP3 CEP170B HSP90AA1 DNMT1

1.51e-089631131728671696
Pubmed

Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP).

CACNA1C CACNA1D CACNA1S

3.34e-083113317767505
Pubmed

Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes.

CACNA1C CACNA1D CACNA1S

3.34e-08311332173707
Pubmed

Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels.

CACNA1C CACNA1D CACNA1S

3.34e-083113317289261
Pubmed

Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.

CACNA1C CACNA1D CACNA1S

1.33e-074113320937870
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

SLK TRIO RTCB KALRN MYO7A SPTAN1 GRIN2B PLEKHG5 ELFN2 GFAP STRIP1 DST SCN2A HSPA4 PRRC2A THRAP3 TARS1 CEP170B HSP90AA1

1.77e-0714311131937142655
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

RANBP2 RTCB SPTAN1 NUP98 KRI1 GFAP ATP10D DKC1 HSPA4 THRAP3 TARS1 HSP90AA1 DNMT1

1.79e-076411131336057605
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

RANBP2 HLA-A RTCB CALU SPTAN1 AGPAT4 KRI1 PSMD7 CLCC1 DST MTOR DKC1 GNAS EMC2 HSPA4 PRRC2A HSPA6 THRAP3 HSP90AA1

1.95e-0714401131930833792
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

ATRX RTCB RPAP3 SPTAN1 CHD1 CAMK1 DST MTOR DKC1 HSPA4 TARS1 HSP90AA1

1.99e-075381131228524877
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

RANBP2 RTCB SPTAN1 NUP98 KRI1 CHD1 CHD2 ESF1 DST MTOR HSPA4 PRRC2A DNMT1

2.21e-076531131322586326
Pubmed

Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.

EHBP1 RANBP2 SLK CLCC1 SCML2 DST PRRC2A THRAP3

2.23e-07191113831177093
Pubmed

The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.

RPAP3 KRI1 PSMD7 ESF1 DST SSH1 GNAS HSPA4 PRRC2A HSPA6 ZMYM4 HSP90AA1

2.38e-075471131237267103
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

SLK RTCB RPAP3 SPTAN1 ESF1 SCML2 TET1 PRRC2A HSPA6 THRAP3 ZMYM4 DNMT1

2.47e-075491131238280479
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

HLA-A ATRX RPAP3 CALU SPTAN1 PIK3R3 KRI1 TWNK CHD1 PSMD7 CLCC1 ESF1 GNAS EMC2 HSPA4 DEPDC1B HSPA6 TARS1 DNMT1

3.19e-0714871131933957083
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

EHBP1 RANBP2 SLK HLA-A SPTAN1 NUP98 CLCC1 RMDN3 DST LPCAT2 HSPA4 HSP90AA1

3.55e-075681131237774976
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

RANBP2 RTCB RPAP3 SPTAN1 CHD1 PSMD7 CHD2 MSH3 ESF1 DST RBM7 DKC1 HSPA4 HSPA6 THRAP3 TARS1 HSP90AA1 DNMT1

3.78e-0713531131829467282
Pubmed

Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes.

RPAP3 MTOR HSPA4 HSP90AA1

3.94e-0719113420801936
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

RANBP2 ATRX RTCB NUP98 KRI1 CHD1 ESF1 SCML2 RBM7 DKC1 PRRC2A THRAP3 ZMYM4 HSP90AA1 DNMT1

4.98e-079541131536373674
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CACNA1C RANBP2 ATRX SPTAN1 NUP98 TWNK PSMD7 CHD2 RNF17 ESF1 CAPN11 DST DKC1 PDIA2 EMC2 HSPA6 THRAP3 HSP90AA1

9.46e-0714421131835575683
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

RANBP2 RTCB RPAP3 SSH1 DKC1 PRPF39 PRRC2A THRAP3

9.74e-07232113825515538
Pubmed

Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice.

CACNA1C CACNA1D CACNA1S

1.16e-067113312900400
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

SLK HLA-A RTCB RPAP3 CALU PARG KRI1 PSMD7 RBM7 DKC1 CCDC9 DNMT1

1.53e-066531131233742100
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

CACNA1C SPTAN1 GRIN2B ELFN2 STRIP1 DST MAPK10 PRRC2A CEP170B

2.12e-06347113917114649
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

CALU SPTAN1 GFAP LPCAT2 C3 CPLANE1 IQCM HSPA4 HSPA6 THRAP3 HSP90AA1

2.42e-065641131121565611
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RANBP2 HLA-A RTCB CALU SPTAN1 NUP98 ESF1 NHS INAVA GNAS HSPA4 PRRC2A CCDC9 THRAP3 TARS1 HSP90AA1

2.86e-0612471131627684187
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

SLK RTCB SPTAN1 NUP98 MSH3 DST HSPA4 PRRC2A HSP90AA1

2.86e-06360113933111431
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

SPTAN1 KRI1 ESF1 PRPF39 HSPA4 PRRC2A THRAP3 HSP90AA1

3.36e-06274113834244482
Pubmed

HES1 is a novel interactor of the Fanconi anemia core complex.

SPTAN1 HSPA4 HSP90AA1

3.94e-0610113318550849
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

RANBP2 RTCB CALU NUP98 KRI1 TWNK CHD1 RBM7 DKC1 PRRC2A THRAP3 ZMYM4 HSP90AA1

3.95e-068471131335850772
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

TRIO KALRN SPTAN1 GRIN2B MTOR GNAS MAPK10 CEP170B

4.04e-06281113828706196
Pubmed

A human MAP kinase interactome.

EHBP1 RANBP2 SPTAN1 NUP98 GFAP RMDN3 DST CPLANE1 MAPK10 HSP90AA1

4.45e-064861131020936779
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

KIAA0408 RANBP2 MYOM1 TRIO KALRN MKRN1 CHD2 DST ZMYM4 HSP90AA1

5.42e-064971131023414517
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

RANBP2 ATRX RTCB SPTAN1 CHD2 MSH3 SCML2 DKC1 PRRC2A

5.94e-06394113927248496
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

RANBP2 KALRN CALU NUP98 STRIP1 RBM7 DKC1 NHS PRRC2A THRAP3

6.02e-065031131016964243
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RANBP2 ATRX RTCB MKRN1 TWNK CHD1 CHD2 ESF1 STRIP1 RMDN3 SCML2 DST RBM7 PRRC2A HSPA6 CEP170B ZMYM4

6.90e-0614971131731527615
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

RANBP2 RTCB NUP98 CHD1 SCML2 HSPA6 THRAP3 ZMYM4 HSP90AA1

8.33e-06411113935182466
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

RANBP2 ESS2 ATRX CHD1 MSH3 ESF1 ZMYM4

8.55e-06222113737071664
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

ATRX KRI1 IRF4 ESF1 DKC1 THRAP3

9.32e-06148113632538781
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

RANBP2 TRIO RTCB SPTAN1 OSBPL1A GNAS HSPA4 PRRC2A HSPA6 THRAP3 HSP90AA1 DNMT1 ENOX2

9.80e-069221131327609421
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

KIAA0408 ZNF211 TRIO KALRN SPTAN1 DST

1.04e-05151113617043677
Pubmed

Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation.

HSPA4 HSP90AA1

1.05e-052113226565746
Pubmed

Temporal expression of calcium channel subunits in satellite cells and bone marrow mesenchymal cells.

CACNA1C CACNA1S

1.05e-052113225277766
Pubmed

Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.

CDC14C CDC14B

1.05e-052113219923902
Pubmed

The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.

CDC14C CDC14B

1.05e-052113221502810
Pubmed

A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice.

CACNA1C CACNA1S

1.05e-05211321281468
Pubmed

Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells.

CACNA1C CACNA1D

1.05e-052113221054386
Pubmed

Protein kinase D regulates the human cardiac L-type voltage-gated calcium channel through serine 1884.

CACNA1C PRKD1

1.05e-052113222100296
Pubmed

Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.

CDC14C CDC14B

1.05e-052113218547142
Pubmed

[In vitro study of expression and effects of HSP70/HSP90 in nasopharyngeal carcinoma cells after thermotherapy].

HSPA4 HSP90AA1

1.05e-052113219764559
Pubmed

An improved targeted cAMP sensor to study the regulation of adenylyl cyclase 8 by Ca2+ entry through voltage-gated channels.

CACNA1C CACNA1D

1.05e-052113224086669
Pubmed

Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.

HSPA4 HSP90AA1

1.05e-052113226556859
Pubmed

[Association between expressions of HSP70, HSP90 and efficacy of chemotherapy in colorectal cancer patients with unresectable liver metastasis].

HSPA4 HSP90AA1

1.05e-052113219598015
Pubmed

Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.

CACNA1C CACNA1D

1.05e-052113226049024
Pubmed

Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.

CACNA1C CACNA1D

1.05e-052113219225208
Pubmed

Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB.

CACNA1C CACNA1D

1.05e-052113216706838
Pubmed

Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures.

CACNA1C CACNA1D

1.05e-052113223761887
Pubmed

Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits.

CACNA1C CACNA1D

1.05e-052113214981074
Pubmed

CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.

CACNA1C CACNA1D

1.05e-052113225292336
Pubmed

Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle.

CACNA1C CACNA1D

1.05e-052113217526649
Pubmed

Kalirin binds the NR2B subunit of the NMDA receptor, altering its synaptic localization and function.

KALRN GRIN2B

1.05e-052113221880917
Pubmed

Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains.

CACNA1D CACNA1S

1.05e-052113228978442
Pubmed

Ligand-activated signal transduction in the 2-cell embryo.

CACNA1C CACNA1D

1.05e-052113212606379
Pubmed

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.

CACNA1C CACNA1D

1.05e-052113224941892
Pubmed

Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.

TET1 DNMT1

1.05e-052113221311766
Pubmed

Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells.

CACNA1C CACNA1D

1.05e-052113222826131
Pubmed

Transcriptional regulation of L-type calcium channel subtypes Cav1.2 and Cav1.3 by nicotine and their potential role in nicotine sensitization.

CACNA1C CACNA1D

1.05e-052113224470632
Pubmed

An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.

HLA-A MSH3

1.05e-052113222110587
Pubmed

Mechanism of JNK signal regulation by placental HSP70 and HSP90 in endothelial cell during preeclampsia.

HSPA4 HSP90AA1

1.05e-052113222409343
Pubmed

DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.

TET1 DNMT1

1.05e-052113223938174
Pubmed

Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.

TRIO KALRN

1.05e-052113226858404
Pubmed

Cav1.2 and Cav1.3 L-type calcium channels operate in a similar voltage range but show different coupling to Ca(2+)-dependent conductances in hippocampal neurons.

CACNA1C CACNA1D

1.05e-052113224760982
Pubmed

Super-enhancer switching drives a burst in gene expression at the mitosis-to-meiosis transition.

SCML2 MYBL1

1.05e-052113232895557
Pubmed

Deletion of the L-type calcium channel Ca(V) 1.3 but not Ca(V) 1.2 results in a diminished sAHP in mouse CA1 pyramidal neurons.

CACNA1C CACNA1D

1.05e-052113220014384
Pubmed

A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.

HSPA4 HSP90AA1

1.05e-052113219758187
Pubmed

Role of putative voltage-sensor countercharge D4 in regulating gating properties of CaV1.2 and CaV1.3 calcium channels.

CACNA1C CACNA1D

1.05e-052113230001160
Pubmed

CHD1 and CHD2 are positive regulators of HIV-1 gene expression.

CHD1 CHD2

1.05e-052113225297984
Pubmed

Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.

CACNA1C CACNA1D

1.05e-052113221352396
Pubmed

GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases.

GRIN2B GFAP

1.05e-052113226081945
Pubmed

Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.

HSPA4 HSP90AA1

1.05e-052113236078164
Pubmed

Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells.

CACNA1C CACNA1D

1.05e-052113217409250
Pubmed

Neuronal L-type calcium channels open quickly and are inhibited slowly.

CACNA1C CACNA1D

1.05e-052113216267232
Pubmed

Hsp70/Hsp90 chaperone machinery is involved in the assembly of the purinosome.

HSPA4 HSP90AA1

1.05e-052113223359685
Pubmed

The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.

CACNA1C CACNA1D

1.05e-052113224996399
Pubmed

HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.

RANBP2 NUP98

1.05e-052113221423673
Pubmed

Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape.

SCHIP1 PDE8A

1.05e-052113227560698
Pubmed

Tet1 regulates epigenetic remodeling of the pericentromeric heterochromatin and chromocenter organization in DNA hypomethylated cells.

TET1 DNMT1

1.05e-052113234166371
Pubmed

Selective formation of Gsalpha-MHC I complexes after desensitization of human platelets with iloprost.

HLA-A GNAS

1.05e-05211329914489
Pubmed

Genetic, cellular, and functional evidence for Ca2+ inflow through Cav1.2 and Cav1.3 channels in murine spiral ganglion neurons.

CACNA1C CACNA1D

1.05e-052113224849370
Pubmed

Endogenous cardiac Ca2+ channels do not overcome the E-C coupling defect in immortalized dysgenic muscle cells: evidence for a missing link.

CACNA1C CACNA1S

1.05e-05211327635187
Pubmed

Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer.

HSPA4 HSP90AA1

1.05e-052113224718854
Pubmed

Divide and conquer: an L-type voltage-gated calcium channel subtype finds a role in conditioned fear.

CACNA1C CACNA1D

1.05e-052113217015854
Pubmed

Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage.

RBP4 GFAP

1.05e-052113226526443
Pubmed

[The expression of genes encoding the voltage-dependent L-type Ca2+ channels in proliferating and differentiating C2C12 myoblasts of mice].

CACNA1D CACNA1S

1.05e-052113221789999
InteractionYWHAH interactions

EHBP1 TRIO RTCB SPTAN1 TWNK PSMD7 PLEKHG5 DNAH7 RMDN3 DST SSH1 MTOR TET1 ZNF286B RBM7 NHS PRKD1 HSPA4 DEPDC1B TARS1 CEP170B HSP90AA1 DNMT1

3.84e-08110211323int:YWHAH
InteractionYWHAG interactions

KIAA0408 EHBP1 SLK RTCB RPAP3 SPTAN1 PLEKHG5 DNAH7 RMDN3 DST SSH1 MTOR TET1 RBM7 NHS PRKD1 GNAS HSPA4 DEPDC1B THRAP3 CEP170B HSP90AA1 DNMT1

3.58e-07124811323int:YWHAG
InteractionNAA40 interactions

EHBP1 RANBP2 SLK ATRX RTCB RPAP3 PARG NUP98 CHD1 PSMD7 ESF1 SCML2 DST DKC1 HSPA4 PRRC2A DEPDC1B HSP90AA1 DNMT1

2.02e-0697811319int:NAA40
InteractionACE2 interactions

CACNA1C RANBP2 HLA-A RTCB SPTAN1 PARG NUP98 KRI1 PSMD7 MSH3 GFAP ATP10D DKC1 GNAS HSPA4 HSPA6 THRAP3 TARS1 HSP90AA1 DNMT1

3.13e-06110611320int:ACE2
InteractionNPHP4 interactions

RPAP3 CALU SPTAN1 GFAP CPLANE1 IQCM HSPA6 THRAP3 HSP90AA1

7.38e-062361139int:NPHP4
InteractionYAP1 interactions

SLK ESS2 RPAP3 SPTAN1 CHD1 GFAP ESF1 SCML2 TET1 PRKD1 GNAS HSPA4 PRRC2A HSPA6 THRAP3 TARS1 ZMYM4 HSP90AA1 DNMT1

1.03e-05109511319int:YAP1
InteractionCALM1 interactions

CACNA1C RANBP2 ESS2 ATRX MYO7A CAMTA2 CAMK1 GRIN2B DST SCN2A PRKD1 GNAS HSPA4 HSP90AA1

1.09e-0562611314int:CALM1
InteractionYWHAQ interactions

CACNA1S SLK RTCB CALU PLEKHG5 DNAH7 RMDN3 DST SSH1 MTOR TET1 RBM7 NHS PRKD1 HSPA4 BANK1 CEP170B HSP90AA1 DNMT1

1.38e-05111811319int:YWHAQ
InteractionFBXW11 interactions

RANBP2 RTCB RPAP3 CHD1 PLEKHG5 SSH1 DKC1 INAVA PRPF39 PRRC2A THRAP3 HSP90AA1

1.41e-0547311312int:FBXW11
InteractionNOS1 interactions

CAMK1 GRIN2B PRKD1 HSPA4 HSP90AA1

3.71e-05671135int:NOS1
InteractionRHBDF2 interactions

EHBP1 RANBP2 SLK CLCC1 SCML2 DST PRRC2A

4.54e-051681137int:RHBDF2
InteractionCDKL2 interactions

KRI1 DKC1 GNAS THRAP3 HSP90AA1

4.92e-05711135int:CDKL2
InteractionUBASH3A interactions

KIAA0408 MKRN1 GFAP HSPA4 HSPA6 HSP90AA1

7.10e-051241136int:UBASH3A
InteractionKCTD13 interactions

SLK TRIO RTCB KALRN MYO7A SPTAN1 TWNK GRIN2B PLEKHG5 ELFN2 GFAP STRIP1 DST SCN2A HSPA4 PRRC2A THRAP3 TARS1 CEP170B HSP90AA1

8.84e-05139411320int:KCTD13
InteractionFBXL6 interactions

RPAP3 KRI1 PSMD7 ESF1 DST SSH1 GNAS HSPA4 PRRC2A HSPA6 ZMYM4 HSP90AA1

1.06e-0458311312int:FBXL6
InteractionCLEC4D interactions

HLA-A CALU SPTAN1 MSH3 CLCC1 DKC1 GNAS EMC2

1.13e-042611138int:CLEC4D
InteractionYWHAZ interactions

SLK SPTAN1 PLEKHG5 GFAP RMDN3 DST SSH1 MTOR RBM7 DKC1 NHS C3 PRKD1 HSPA4 PRRC2A DEPDC1B CEP170B HSP90AA1 DNMT1

1.29e-04131911319int:YWHAZ
InteractionRHBDD1 interactions

EHBP1 RANBP2 SLK CLCC1 SCML2 LPCAT2 C3 PRRC2A THRAP3

1.46e-043461139int:RHBDD1
InteractionTERF1 interactions

RPAP3 SPTAN1 DST MTOR BIN2 HSPA4 CCDC9 HSPA6 HSP90AA1

1.49e-043471139int:TERF1
InteractionPABPC5 interactions

MKRN1 KRI1 TWNK RBM7 DKC1 CCDC9

1.50e-041421136int:PABPC5
InteractionCIT interactions

RANBP2 RTCB KALRN RPAP3 CALU SPTAN1 NUP98 KRI1 CHD1 CHD2 GRIN2B GFAP ESF1 DKC1 GNAS MMP15 PRRC2A HSPA6 THRAP3 HSP90AA1

1.51e-04145011320int:CIT
InteractionDOT1L interactions

RANBP2 ATRX RTCB CALU NUP98 KRI1 TWNK CHD1 RBM7 PRRC2A THRAP3 TARS1 ZMYM4 HSP90AA1

1.69e-0480711314int:DOT1L
InteractionMYO3B interactions

RPAP3 CALU KRI1 HSP90AA1

1.77e-04501134int:MYO3B
InteractionAGAP2 interactions

TRIO KALRN SPTAN1 GRIN2B GNAS MAPK10 CEP170B

1.83e-042101137int:AGAP2
InteractionTTC41P interactions

TTC41P SPTAN1

1.86e-0441132int:TTC41P
InteractionUSP9Y interactions

KIAA0408 USP9Y PRKD1 CCDC9

1.91e-04511134int:USP9Y
InteractionNEUROG3 interactions

SPTAN1 GRIN2B RMDN3 DST LPCAT2 ZMYM4

1.95e-041491136int:NEUROG3
InteractionMYCN interactions

ESS2 HLA-A RTCB CALU MKRN1 PSMD7 CHD2 GFAP ESF1 RBM7 DKC1 C3 PRPF39 HSPA4 PRRC2A CCDC9 THRAP3 HSP90AA1 DNMT1

2.17e-04137311319int:MYCN
GeneFamilyCalcium voltage-gated channel subunits

CACNA1C CACNA1D CACNA1S

1.73e-0426763253
GeneFamilyEF-hand domain containing

CALU SPTAN1 DNAH7 CAPN11 DST LPCAT2

3.18e-04219766863
GeneFamily1-acylglycerol-3-phosphate O-acyltransferases

AGPAT4 LPCAT2

9.36e-041176246
GeneFamilyZinc fingers CXXC-type

TET1 DNMT1

1.12e-0312762136
GeneFamilyATPase phospholipid transporting

ATP10D ATP11B

1.77e-03157621210
GeneFamilyHeat shock 70kDa proteins

HSPA4 HSPA6

2.28e-0317762583
GeneFamilyDNA helicases

TWNK CHD2

2.28e-03177621167
GeneFamilyEndogenous ligands|Matrix metallopeptidases

MMP10 MMP15

4.53e-0324762891
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

EHBP1 SCHIP1 SLK PDE8A CRIM1 ATRX TRIO PARG NUP98 CHD1 DST ATP11B ZMYM4 MYBL1

1.43e-0846611314M13522
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

EHBP1 RANBP2 SCHIP1 SLK PDE8A CRIM1 ATRX TRIO PARG NUP98 CHD1 MSH3 DST ATP11B EMC2 ZMYM4 MYBL1

1.57e-0785611317M4500
CoexpressionGSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP

CRIM1 HLA-A TRIO PSMD7 MAD2L1BP C3 SMPD1 HSP90AA1

2.39e-061981138M6123
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

SLK RPAP3 CHD1 C1GALT1 MSH3 ESF1 OSBPL1A EMC2 CPLANE1 PRPF39 HSP90AA1 MYBL1 ENOX2

5.21e-0665611313M18979
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

RANBP2 SLK HLA-A ATRX MYO7A SPTAN1 NUP98 KRI1 SPOCK2 CHD1 CHD2 ATP11B SSH1 DSTYK BIN2 SAMD3 GNAS THRAP3 DNMT1 MYBL1

5.53e-06149211320M40023
CoexpressionGSE17721_CTRL_VS_POLYIC_8H_BMDC_DN

CACNA1D PARG CHD1 RNF17 PRKD1 MAPK10 CCDC9

2.56e-051991137M3718
CoexpressionGSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP

PIK3R3 AGPAT4 IRF4 CAPN11 LPCAT2 DKC1 ZMYM4

2.64e-052001137M9390
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

RBM44 PDE8A PIK3R3 MKRN1 PARG RNF17 ESF1 SCML2 ATP11B MTOR TET1 DKC1 CPLANE1 HSP90AA1 MYBL1

1.93e-0582010915gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_500

RBM44 RNF17 ESF1 SCML2 MYBL1

1.95e-05641095gudmap_developingGonad_e16.5_ovary_500_k2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

RANBP2 ATRX RPAP3 CHD2 CLCC1 ESF1 GPR137C HSPA4 MYBL1

3.27e-053111099Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_500

RBM44 RNF17 ESF1 SCML2 GPR137C MYBL1

3.29e-051181096gudmap_developingGonad_e14.5_ ovary_500_k3
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500

RBM44 ATRX PSMD7 CHD2 RNF17 ESF1 SCML2 TET1 DKC1 MYBL1

4.35e-0540310910gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

RBM44 RPAP3 PARG RNF17 ESF1 ATP11B DKC1 HSP90AA1

6.96e-052661098gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

RANBP2 RPAP3 SPTAN1 PARG CHD1 C1GALT1 ESF1 PRPF39 HSPA4 THRAP3 DNMT1

9.23e-0553210911Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

RBM44 PARG RNF17 ESF1 ATP11B MTOR DKC1 CPLANE1 HSP90AA1

1.03e-043611099gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_1000

RBM44 RNF17 ESF1 SCML2

1.36e-04511094gudmap_developingGonad_e12.5_ovary_k2_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_1000

RBM44 RNF17 ESF1 SCML2 MYBL1

1.44e-04971095gudmap_developingGonad_e18.5_ovary_1000_k1
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500

RBM44 ATRX CHD2 RNF17 ESF1 ENO4 SCML2 CPLANE1 MYBL1

1.73e-043871099gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_500

RBM44 RNF17 ESF1

2.16e-04231093gudmap_developingGonad_e12.5_testes_k5_500
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000

RBM44 RNF17 ESF1 SCML2 MYBL1

2.28e-041071095gudmap_developingGonad_e16.5_ovary_1000_k4
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_500

RBM44 RNF17 SCML2 MYBL1

2.41e-04591094gudmap_developingGonad_e12.5_epididymis_k1_500
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000

RBM44 ATRX MKRN1 PSMD7 CHD2 RNF17 ESF1 SCML2 TET1 DKC1 CPLANE1 THRAP3 MYBL1

2.51e-0480610913gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500

RBM44 CRIM1 ATRX MYO7A SPOCK2 PSMD7 ESF1 SCML2 PRRC2A

2.56e-044081099gudmap_developingGonad_P2_testes_500
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000

RBM44 RPAP3 SPTAN1 MKRN1 PARG RNF17 ESF1 SCML2 MTOR TET1 CPLANE1 HSP90AA1 MYBL1

2.63e-0481010913gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500

RBM44 ATRX MYO7A PSMD7 USP9Y RNF17 ESF1 SCML2 PRRC2A

2.71e-044111099gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000

RBM44 CRIM1 ATRX MYO7A SPOCK2 PSMD7 CAMK1 USP9Y RNF17 ESF1 SCML2 DST PRRC2A

2.92e-0481910913gudmap_developingGonad_P2_testes_1000
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000

RBM44 RPAP3 MKRN1 PARG RNF17 SCML2 ATP11B MTOR TET1 DKC1 CPLANE1 HSP90AA1 MYBL1

3.03e-0482210913gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_100

RBM44 RNF17 SCML2

3.14e-04261093gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_100
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000

RBM44 MKRN1 RNF17 ESF1

3.50e-04651094gudmap_developingGonad_e12.5_epididymis_k2_1000
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_500

CRIM1 SCN2A C3

3.93e-04281093gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_500
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100

RBM44 RNF17 SCML2 MYBL1

4.64e-04701094gudmap_developingGonad_e14.5_ ovary_100
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_100

RBM44 RNF17 SCML2

5.33e-04311093gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_100
CoexpressionAtlasDevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000

SCHIP1 SLK PDE8A ATRX TRIO MYO7A ATP10D LPCAT2 MMP15 PRPF39 DEPDC1B BANK1

5.36e-0476110912gudmap_developingKidney_e15.5_Endothelial cells_1000
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000

RBM44 RNF17 ESF1 SCML2

5.73e-04741094gudmap_developingGonad_e14.5_ testes_1000_k3
CoexpressionAtlasdev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000

SCHIP1 PDE8A CRIM1 MYO7A MKRN1 AGPAT4 CDC14B DST SSH1 LPCAT2 PRKD1 MMP15 MYBL1

5.77e-0488010913gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlasNK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3

CRIM1 TRIO CDC14B ATP11B SSH1 BIN2 SAMD3 BANK1

6.72e-043721098GSM538288_500
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_500

CRIM1 ATRX PSMD7 ESF1 PRRC2A

6.86e-041361095gudmap_developingGonad_P2_testes_500_k3
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_200

RBM44 RNF17 SCML2

7.01e-04341093gudmap_developingGonad_e18.5_ovary_200_k2
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_100

RNF17 SCML2 MYBL1

7.01e-04341093gudmap_developingGonad_e14.5_ ovary_100_k5
CoexpressionAtlasalpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3

CRIM1 HLA-A TRIO CDC14B ATP10D ATP11B BIN2 SAMD3

7.20e-043761098GSM605894_500
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_200

RBM44 MKRN1 RNF17 SCML2 TET1

7.57e-041391095gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_200
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_200

RBM44 RNF17 SCML2 TET1 MYBL1

7.57e-041391095gudmap_dev gonad_e13.5_M_GermCell_Oct_200
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500

RBM44 ATRX RNF17 SCML2 CPLANE1 MAPK10 BANK1 MYBL1

7.59e-043791098gudmap_developingGonad_P2_ovary_500
CoexpressionAtlasalpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3

HLA-A TRIO CDC14B ATP10D ATP11B BIN2 SAMD3 DEPDC1B

7.72e-043801098GSM605901_500
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

RBM44 ATRX CHD2 RNF17 DNAH7 ESF1 ENO4 SCML2 ATP11B PRKD1 CPLANE1 MYBL1

7.87e-0479510912gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000

RBM44 RPAP3 MKRN1 PARG RNF17 ESF1 SCML2 ATP11B TET1 DKC1 HSP90AA1 MYBL1

7.87e-0479510912gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500

RBM44 ATRX RNF17 ESF1 SCML2 GPR137C CPLANE1 MYBL1

7.98e-043821098gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlasalpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3

CRIM1 HLA-A TRIO CDC14B ATP10D ATP11B BIN2 SAMD3

8.12e-043831098GSM538403_500
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

RBM44 ATRX CHD2 RNF17 ESF1 SCML2 TET1 DKC1 PRKD1 CPLANE1 THRAP3 MYBL1

8.67e-0480410912gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500

RBM44 ATRX CHD2 RNF17 SCML2 CPLANE1 MAPK10 MYBL1

8.68e-043871098gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlasDevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000

SCHIP1 ATRX TRIO PRPF39

9.25e-04841094gudmap_developingKidney_e15.5_Endothelial cells_1000_k5
CoexpressionAtlasgamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3

CRIM1 TRIO SPOCK2 LPCAT2 TET1 BIN2 SAMD3 BANK1

9.59e-043931098GSM476672_500
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200

RBM44 ATRX RNF17 SCML2 MAPK10

9.74e-041471095gudmap_developingGonad_e18.5_ovary_200
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200

RBM44 RNF17 SCML2 TET1 MYBL1

9.74e-041471095gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200
ToppCell343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells)

MYO7A CLCC1 ATP11B DSTYK TET1 SAMD3 HSPA6

5.29e-0718811378f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

ATRX KRI1 CHD2 ESF1 PRRC2A HSP90AA1 DNMT1

7.24e-0719711370fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1C KALRN SPTAN1 GRIN2B SCN2A GNAS MAPK10

7.49e-0719811378ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PARG IRF4 ESF1 PRPF39 BANK1 ENOX2

4.82e-06170113632917888c3f1d54302675c1d4de1fd3b7c79af5f
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-A SPOCK2 BIN2 SAMD3 FER1L5 MYBL1

5.69e-061751136dddeced0cfcf71d03bcf349983908b3bfb0ab51d
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF211 TWNK IRF4 SPOCK2 SAMD3 MYBL1

5.88e-0617611366b1cf1e98b4509e87f9eea827fa7090ce1e504f1
ToppCellCOVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CACNA1S SPOCK2 ELFN2 TM4SF4 MYBL1

8.29e-06108113504bfb90634b691020f246a8afbebd3bf944d1e0e
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

CACNA1C CRIM1 KALRN DST NHS PRKD1

8.31e-061871136464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|367C / Donor, Lineage, Cell class and subclass (all cells)

HLA-A SPOCK2 BIN2 SAMD3 HSP90AA1 MYBL1

9.10e-0619011364240d52a465bc3f8016834b22a35c44ba2b0a9f4
ToppCellCV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster

HLA-A SPTAN1 SPOCK2 CDC14B SAMD3 MYBL1

9.38e-0619111366776bcc4c1915f0c1062002ff7746f20ceb725f4
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue

HLA-A AGPAT4 USP9Y SAMD3 HSPA6 HSP90AA1

9.38e-061911136db7b8f8826bf19d6eeee14319570a9e6e99ab2cb
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell|367C / Donor, Lineage, Cell class and subclass (all cells)

HLA-A BIN2 SAMD3 HSPA6 HSP90AA1 MYBL1

9.66e-061921136a0bd4a0d00246af4f6645e66a0dedfe36882cc60
ToppCell343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

MYO7A CLCC1 ATP11B DSTYK TET1 HSPA6

9.66e-061921136445985fe1bcd33e4f0a1704b27988fbfc9334538
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

RANBP2 ATRX MSH3 ATP11B CPLANE1 ZMYM4

9.95e-061931136abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|343B / Donor, Lineage, Cell class and subclass (all cells)

HLA-A BIN2 SAMD3 HSPA6 HSP90AA1 MYBL1

1.06e-0519511361af6fd96634236d5910fd085ff2d532862303d6b
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

HLA-A NUP98 IRF4 SPOCK2 RNF17 HSP90AA1

1.09e-051961136ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCellCOVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SPTAN1 SPOCK2 CHD2 USP9Y SAMD3 MYBL1

1.12e-051971136c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D DNAH7 SCN2A NHS PRKD1 MAPK10

1.12e-0519711367e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCellnormal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 BIN2 SAMD3 HSP90AA1 MYBL1

1.12e-0519711364cec48e202f4583c9328d4b722c49ed3471ec173
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HLA-A AGPAT4 SPOCK2 BIN2 SAMD3 MYBL1

1.18e-051991136db05c16d80f5a74bfa048a5c92917d312d26f769
ToppCellMS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_CTL|Multiple_Sclerosis / Disease, condition lineage and cell class

HLA-A AGPAT4 DNAI3 CDC14B SAMD3 MYBL1

1.22e-0520011362e18ce20dc61ae90883139d1b0c29d145888c001
ToppCellcontrol-gd_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SPTAN1 SPOCK2 SAMD3 GNAS HSP90AA1 MYBL1

1.22e-052001136b188f2acb9bd4f5f1ad4c3d3ddb9a55854a8b74b
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

HLA-A SPOCK2 BIN2 SAMD3 HSP90AA1 MYBL1

1.22e-052001136893bb7c25ad7c6589a4c7c0364c2ace666e9b4be
ToppCellsevere-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SPOCK2 BIN2 SAMD3 GNAS HSP90AA1 MYBL1

1.22e-0520011366aa77955017d073a96324e4db6b9950a2ec46cf8
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells)

CCDC60 USP9Y BIN2 SAMD3 MYBL1

3.56e-0514611350e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
ToppCell(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

HLA-A SPOCK2 MMP10 MAPK10 DISP1

5.03e-05157113584f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D MYOM1 SCN2A NHS DEPDC1B

5.50e-0516011358bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1D MYOM1 SCN2A NHS DEPDC1B

5.50e-0516011352d391ba6f7adb55dfa89feecc10cc9ce97e5fe74
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-CD4_CTL|Multiple_Sclerosis / Disease, Lineage and Cell Type

HLA-A AGPAT4 DNAI3 SAMD3 MYBL1

5.84e-051621135d53de64df2511eddba79f899fc3f48b1b059923f
ToppCellTCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9

DNAI3 ELFN2 CLCC1 DST DEPDC1B

6.01e-0516311350e8d3c98209fc98b86b841d69051cee9e276d837
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RNF17 GFAP PDIA2 SAMD3 DEPDC1B

6.01e-051631135924c666596bbb42d7876c9b164a725277f3efa5f
ToppCellnormal_Pleural_Fluid-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass

MYO7A SPOCK2 CAMK1 NHS C3

6.19e-051641135334f376350c9cf92611d0f75b2e18a102f4c116a
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPOCK2 DNAI3 BIN2 SAMD3 HSPA6

6.19e-051641135aff5138b35a06b0819e52855744797bfa343633a
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DNAI3 BIN2 SAMD3 HSPA6 HSP90AA1

6.74e-051671135d80b64322d16d98c82a52724809740b9de208f39
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type

HLA-A SPOCK2 SAMD3 HSP90AA1 MYBL1

7.75e-05172113518bda0038cb37da6784e7bf7291272c108cfd9c5
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

HLA-A KALRN NUP98 DST CEP170B

8.63e-0517611353de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell10x3'2.3-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CRIM1 SPOCK2 PLEKHG5 INAVA SAMD3

8.87e-051771135e1ba7e17af2c54d3c78cdf85882168c5b896e453
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

HLA-A KALRN NUP98 DST CEP170B

8.87e-05177113582fdd6185b368f54f03de389427cbe3071d21a99
ToppCellControl-Lymphocyte-T_NK-CD4_CTL|Control / Disease, Lineage and Cell Type

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

9.10e-05178113532fbb7a8d7daa7cb37f42923514acbb9090e6811
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

9.10e-051781135a96941fef62c2f4533c557ef825ae3265f8f52db
ToppCellIIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

9.10e-0517811353344d1328fd9c570c3a4b2629edec627a442d0e0
ToppCellRA-07._Pericyte|World / Chamber and Cluster_Paper

CACNA1C PDE8A KALRN NHS MAPK10

1.01e-0418211352075efeae633550fb2eb026d0dfd741c8252482e
ToppCellRA-17._Lymphocyte|RA / Chamber and Cluster_Paper

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.01e-041821135257a7847917b6ea1d60608183d90300bfd028758
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CACNA1C TRIO KALRN CDC14B GPR137C

1.01e-041821135ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

BIN2 SAMD3 HSPA6 HSP90AA1 MYBL1

1.04e-041831135983ca1342ddd365e1f1df32a456394b002b10e41
ToppCellnormal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A ATRX SAMD3 HSP90AA1 MYBL1

1.04e-04183113579defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCellRA-17._Lymphocyte|World / Chamber and Cluster_Paper

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.04e-0418311356397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MYOM1 KALRN CAMK1 SCN2A BIN2

1.06e-041841135ba65e3972b2b8d825a2c1a9d03d092cc1afad073
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ELFN2 SLC7A3 LPCAT2 INAVA MMP15

1.06e-041841135278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

PDE8A TRIO DST NHS C3

1.06e-041841135d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ELFN2 SLC7A3 LPCAT2 INAVA MMP15

1.06e-0418411358d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RBP4 AGPAT4 TM4SF4 GNAS HSP90AA1

1.09e-0418511354e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF211 IRF4 SPOCK2 SAMD3 PRPF39

1.09e-041851135f1263899a2d41d182022dc4ca62cbae08a463c89
ToppCellwk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

HLA-A SPOCK2 GFAP BIN2 SAMD3

1.09e-0418511352d95713deaa05fb3372f4337ef156027e4d8ec8a
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF211 IRF4 SPOCK2 SAMD3 PRPF39

1.12e-041861135bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe
ToppCell367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|367C / Donor, Lineage, Cell class and subclass (all cells)

HLA-A SPOCK2 BIN2 SAMD3 HSP90AA1

1.12e-041861135d4be02813d590aa7ffe0d1553a27d257b9ab77fe
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RBP4 AGPAT4 TM4SF4 GNAS HSP90AA1

1.12e-04186113516092819e9148dfe64f07c737652b6e533e699f7
ToppCellControl-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.15e-0418711357fdff970a9397305d0b8194c00a043cc69dcca12
ToppCell3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue

HLA-A ATRX USP9Y DNAI3 SAMD3

1.18e-04188113521730497f95dc271e4cdfaaf1da8b9ac6eec2ded
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

CACNA1C CRIM1 KALRN NHS PRKD1

1.18e-04188113534e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 SAMD3 HSP90AA1 MYBL1

1.18e-0418811352513ca0efa73c09a3406b99e2876982d78b173d7
ToppCellRA-11._Adipocyte|World / Chamber and Cluster_Paper

EHBP1 RBP4 OSBPL1A NHS MAPK10

1.18e-0418811354dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCellhuman_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CRIM1 AGPAT4 C1GALT1 NHS DEPDC1B

1.18e-041881135b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.21e-041891135f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1C CACNA1D DNAI3 NHS PRKD1

1.21e-0418911352a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue

HLA-A ATRX USP9Y BIN2 SAMD3

1.24e-0419011355dca8654964c41580fa3b094579fe7cb296d406f
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ATRX CALU SPTAN1 DST BANK1

1.24e-041901135d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue

HLA-A AGPAT4 BIN2 SAMD3 MYBL1

1.24e-04190113566d29f53f129fc18771f6214316a913eeaccd55e
ToppCell3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue

HLA-A USP9Y BIN2 SAMD3 MYBL1

1.24e-0419011355624f711b34132081f93fa70702316962e3e3c64
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.27e-041911135b2d0ea24970da09209da9d9dda76e30fbfe22917
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CRIM1 SPOCK2 PDIA2 C3 DISP1

1.27e-0419111355343a527de6b0f852f45020a91f5b4869e78f13a
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CACNA1C KALRN NUP98 SSH1 NHS

1.27e-04191113508720998aa55131d7377c4c67c4c935865bd7d79
ToppCelltumor_Lung-T/NK_cells-Exhausted_Tfh|tumor_Lung / Location, Cell class and cell subclass

HLA-A MYO7A SPOCK2 CHD1 CAMK1

1.27e-0419111353e259eba83f8159d1a1a96b98d0e867fe547c5e7
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CRIM1 SPOCK2 PDIA2 C3 DISP1

1.27e-041911135a25a5f9a380031fdaf57677a079f97a90f0550c0
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

RANBP2 NUP98 CHD1 CHD2 BANK1

1.27e-0419111351ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

EHBP1 CACNA1C CACNA1D KALRN MAPK10

1.27e-041911135fa380a8752de158974b2ae5e741573439719cc0d
ToppCellnormal-na-Lymphocytic_T-CytoT_GZMK+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 SAMD3 HSP90AA1 MYBL1

1.27e-0419111352ad34ccd55362db04511c90cf264ae5b93b48dde
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AGPAT4 DST BIN2 SAMD3 MYBL1

1.30e-041921135df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCellURO-Lymphocyte-T_NK-CD8_TEM|URO / Disease, Lineage and Cell Type

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.30e-04192113531b6d068f7adc6952c4cf625df851a10cb1b00c9
ToppCellnormal-na-Lymphocytic_T-CytoT_GZMK+|normal / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 SAMD3 HSP90AA1 MYBL1

1.30e-0419211357460ce6e2f91bbf940b684f63231db7501ace09f
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 SAMD3 HSP90AA1 MYBL1

1.30e-04192113571bc03b08cda0382ea45b503d5f4f135ed98cc11
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.30e-04192113501d01c9293f2439dc4c34c648273319c9beee5c7
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.30e-041921135fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.30e-0419211350f8c63de26128694f4522f9f6d029e4628c890bc
ToppCellLPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SCHIP1 KALRN PIK3R3 SPOCK2 GRIN2B

1.30e-041921135717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue

HLA-A USP9Y BIN2 SAMD3 MYBL1

1.30e-041921135ab88ea7723f0fa3b39611981c043445f27425404
ToppCellwk_15-18-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.30e-041921135fedff776812c3d040d295ac8c806296e4018b247
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

NUP98 GPR137C HSPA4 HSPA6 HSP90AA1

1.30e-0419211353f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1C CACNA1D DNAI3 NHS PRKD1

1.30e-041921135deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue

HLA-A AGPAT4 BIN2 SAMD3 MYBL1

1.33e-041931135e325cf49e159c6be205ed93adaa09efdd0c122b4
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HLA-A PIK3R3 SPOCK2 NHS GNAS

1.33e-0419311359f9eb241b0b82a6f12de6921c3acf6fed7cf65bb
ToppCellCD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

HLA-A SPTAN1 SPOCK2 CDC14B SAMD3

1.33e-041931135995781d87a919c0380750878bafe584342bb83ad
ToppCellCOVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class

HLA-A USP9Y SAMD3 HSP90AA1 MYBL1

1.33e-041931135ddc1db516568e03be8e82b2ca770c67756418185
ToppCell367C-Lymphocytic|367C / Donor, Lineage, Cell class and subclass (all cells)

HLA-A SPOCK2 BIN2 SAMD3 HSP90AA1

1.33e-041931135b069a1cba2e1bf1c0d7479b11185fb416f18b14b
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CCDC60 DNAI3 DNAH7 CPLANE1 MAPK10

1.33e-041931135ea345d34440b25f65358a53dc72831998d1c3620
ToppCellControl-Lymphocyte-T_NK|Control / Disease, Lineage and Cell Type

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.33e-041931135eb8b8f6e52fd140fbacf3d6776458c6fc355e120
ToppCellLAM-Lymphoid|LAM / Condition, Lineage and Cell class

HLA-A SPOCK2 BIN2 SAMD3 MYBL1

1.33e-0419311359495134779bce4997f8b21d8921bfd5af17f050b
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

CACNA1C CACNA1D DST NHS PRKD1

1.33e-041931135e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellPosterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

ATRX GRIN2B SCN2A MAPK10 HSP90AA1

1.33e-041931135b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCellControl-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

CACNA1C CACNA1D CRIM1 DST PRKD1

1.33e-0419311355896242f713ae5fd1a4ebb63827f15d7279dced2
DrugNisoldipine

CACNA1C CACNA1D CACNA1S

1.15e-0651123DB00401
DrugNilvadipine

CACNA1C CACNA1D CACNA1S

1.15e-0651123DB06712
DrugBAPTA-AM

CACNA1C CACNA1D CALU PIK3R3 CAMK1 GRIN2B SMPD1 PRKD1 MAPK10 HSP90AA1

1.90e-0629311210CID000002293
DrugAC1L1DXE

CACNA1C CACNA1D CACNA1S PIK3R3 GRIN2B GFAP MTOR PRKD1 MAPK10 ENOX2

2.28e-0629911210CID000002548
DrugCPU-23

CACNA1C CACNA1D CACNA1S

2.29e-0661123CID003036051
DrugAmlodipine

CACNA1C CACNA1D CACNA1S

4.00e-0671123DB00381
DrugIsradipine

CACNA1C CACNA1D CACNA1S

4.00e-0671123DB00270
Drugthioflavin T

CAMK1 GRIN2B GFAP MTOR MAPK10 HSPA4 HSP90AA1

6.34e-061411127CID000016953
DrugNifedipine

CACNA1C CACNA1D CACNA1S

6.37e-0681123DB01115
DrugNitrendipine

CACNA1C CACNA1D CACNA1S

6.37e-0681123DB01054
Druggenistein

CACNA1C CACNA1D CACNA1S CALU PIK3R3 GFAP CLCC1 DST MTOR TET1 C3 PRKD1 MMP10 MAPK10 MMP15 DEPDC1B HSP90AA1 DNMT1

8.45e-06111711218CID005280961
DrugCinnarizine

CACNA1C CACNA1D CACNA1S

9.53e-0691123DB00568
DrugNimodipine

CACNA1C CACNA1D CACNA1S

9.53e-0691123DB00393
DrugEGTA-AM

CACNA1C CACNA1D RANBP2 CAMK1 HSPA4

1.36e-05621125CID000121907
DrugMibefradil

CACNA1C CACNA1D CACNA1S

1.86e-05111123DB01388
DrugFelodipine

CACNA1C CACNA1D CACNA1S

1.86e-05111123DB01023
Drugafimoxifene

SCHIP1 CRIM1 PIK3R3 CAMK1 MTOR DKC1 C3 SMPD1 HSPA4 TARS1 MYBL1

2.48e-0547911211ctd:C016601
Drugpapaverine

CACNA1C CACNA1D CACNA1S PDE8A DST TET1 SMPD1

2.68e-051761127CID000004680
Drugfulvestrant

PIK3R3 GRIN2B DST MTOR C3 MMP15 HSPA4 TARS1 HSP90AA1 DNMT1 MYBL1

2.72e-0548411211ctd:C070081
Drugpotassium

CACNA1C CACNA1D CACNA1S CALU PIK3R3 CAMK1 GRIN2B GFAP CLCC1 SLC7A3 ATP11B SCN2A C3 SMPD1 PRKD1 HSPA4

3.40e-05100811216CID000000813
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A

ESS2 CRIM1 TRIO NUP98 TWNK CAMTA2 DSTYK

3.69e-0518511276965_DN
DrugSpotlight

GRIN2B GFAP MTOR HSPA4 HSP90AA1 ENOX2

3.78e-051261126CID000086222
DrugAC1L1JG6

CACNA1C CACNA1D CACNA1S

4.05e-05141123CID000005026
DrugChrysamine-G

GRIN2B GFAP MTOR HSPA4 HSP90AA1

4.18e-05781125CID005488970
DrugFPL 64176

CACNA1C CACNA1D CACNA1S

5.05e-05151123CID000003423
DrugAmprolium hydrochloride [137-88-2]; Down 200; 12.6uM; HL60; HG-U133A

RANBP2 CALU NUP98 KRI1 CLCC1 DKC1 HSPA4

5.15e-0519511271979_DN
DrugDiltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A

SLK ESS2 CRIM1 TRIO CALU CDC14B CEP170B

5.32e-0519611271948_DN
DrugHexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A

ATRX TRIO PIK3R3 KRI1 CAMK1 MAPK10 ENOX2

5.32e-0519611274965_UP
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A

CACNA1D IRF4 RNF17 CDC14B TM4SF4 PDIA2 GNAS

5.67e-0519811274378_DN
DrugPPTP

MTOR HSPA4 HSP90AA1

6.19e-05161123CID000146272
DrugVerapamil

CACNA1C CACNA1D CACNA1S

6.19e-05161123DB00661
Drugchelerythrine

CACNA1C CACNA1D CALU PIK3R3 GRIN2B SMPD1 PRKD1 GNAS HSPA4

6.89e-053571129CID000002703
DrugNBQX

CACNA1C CACNA1D GRIN2B GFAP HSPA4

8.30e-05901125CID003272523
DrugN-methyl-DL-aspartic acid

CACNA1C CACNA1D CACNA1S TRIO PIK3R3 CAMK1 GRIN2B GFAP MTOR PRKD1 GNAS HSPA4

9.32e-0565511212CID000004376
DrugAC1NRC8M

CLCC1 SCN2A PRKD1

1.06e-04191123CID005288877
Drugzebularine

MMP10 HSPA4 HSP90AA1 DNMT1

1.16e-04511124CID000100016
Druggamma-aminobutyric acid

CACNA1C CACNA1D CACNA1S PIK3R3 GRIN2B GFAP CLCC1 SMPD1 HSPA6 DNMT1

1.18e-0447411210CID000000119
DrugCL-387,785

MTOR PRKD1 HSP90AA1

1.24e-04201123CID000002776
DrugCGP7040

MAPK10 HSPA4 HSP90AA1

1.24e-04201123CID006436259
DiseaseTimothy syndrome (implicated_via_orthology)

CACNA1C CACNA1D CACNA1S

2.01e-0741103DOID:0060173 (implicated_via_orthology)
DiseaseEpileptic encephalopathy

CHD2 GRIN2B MTOR MAPK10

4.65e-06301104C0543888
DiseaseDuchenne muscular dystrophy (implicated_via_orthology)

CACNA1C CACNA1D CACNA1S CAPN11

9.82e-06361104DOID:11723 (implicated_via_orthology)
DiseaseEndocrine System Diseases

MTOR GNAS

4.12e-0531102C0014130
DiseaseMetastatic melanoma

TRIO CAMK1 MTOR PRKD1

5.01e-05541104C0278883
DiseaseWest Syndrome

SPTAN1 GRIN2B SCN2A

9.64e-05241103C0037769
Diseaserheumatoid arthritis (is_marker_for)

C3 HSPA4 HSP90AA1 DNMT1

1.31e-04691104DOID:7148 (is_marker_for)
Diseaseserum gamma-glutamyl transferase measurement

EHBP1 ATRX KALRN PIK3R3 TWNK SSH1 TM4SF4 C3 MMP15 HSPA4 PRRC2A DNMT1

1.58e-0491411012EFO_0004532
DiseaseLennox-Gastaut syndrome

CHD2 MAPK10

2.05e-0461102C0238111
DiseaseSclerocystic Ovaries

RBP4 PLEKHG5 LPCAT2 GNAS MYBL1

2.09e-041441105C1136382
DiseasePolycystic Ovary Syndrome

RBP4 PLEKHG5 LPCAT2 GNAS MYBL1

2.09e-041441105C0032460
DiseaseManic

CACNA1C CACNA1D SCN2A HSPA4

2.11e-04781104C0338831
DiseaseEpilepsy, Cryptogenic

CHD2 GRIN2B GFAP SCN2A

2.56e-04821104C0086237
DiseaseAwakening Epilepsy

CHD2 GRIN2B GFAP SCN2A

2.56e-04821104C0751111
DiseaseAura

CHD2 GRIN2B GFAP SCN2A

2.56e-04821104C0236018
DiseaseN4-acetylcytidine measurement

PDE8A CAPN11

2.86e-0471102EFO_0800628
DiseaseNeurodevelopmental Disorders

TRIO CHD2 GRIN2B SCN2A

4.14e-04931104C1535926
DiseaseMood Disorders

CACNA1C CACNA1D HSPA4 HSP90AA1 DNMT1

4.26e-041681105C0525045
DiseaseBipolar Disorder

CACNA1C CACNA1D GRIN2B GFAP SCN2A MMP10 HSPA4 DNMT1

4.27e-044771108C0005586
Diseaseunipolar depression, age at onset

GRIN2B SAMD3 IQCM

4.50e-04401103EFO_0003761, EFO_0004847
Diseaseage at first sexual intercourse measurement

CACNA1D MKRN1 IRF4 STRIP1 SCN2A PRKD1 DEPDC1B

5.95e-043831107EFO_0009749
DiseaseEpilepsy

CHD2 GRIN2B GFAP SCN2A

7.53e-041091104C0014544
Diseaseresponse to trauma exposure

TET1 SAMD3 MAPK10

9.22e-04511103EFO_0008483
DiseaseMalignant Neoplasms

MSH3 MTOR GNAS ENOX2

1.37e-031281104C0006826
DiseaseAntibody Deficiency Syndrome

CACNA1C C3

1.81e-03171102C0003257
Diseaseschizophrenia, inflammatory bowel disease

INAVA BANK1

2.03e-03181102EFO_0003767, MONDO_0005090
Diseaseaspartate aminotransferase measurement

CACNA1S HLA-A KALRN MYO7A C1GALT1 MTOR DSTYK MMP15 PRRC2A BANK1

2.06e-0390411010EFO_0004736
DiseaseMajor Depressive Disorder

CACNA1C KALRN GFAP MTOR HSP90AA1

2.21e-032431105C1269683
Diseasepolycystic kidney disease (biomarker_via_orthology)

MTOR GNAS

2.26e-03191102DOID:0080322 (biomarker_via_orthology)
DiseaseMalignant Glioma

HLA-A ATRX MYBL1

2.30e-03701103C0555198
Diseasemixed gliomas

HLA-A ATRX MYBL1

2.30e-03701103C0259783
DiseaseManic Disorder

CACNA1C CACNA1D SCN2A

2.40e-03711103C0024713
DiseaseUnipolar Depression

CACNA1C KALRN GFAP MTOR HSP90AA1

2.90e-032591105C0041696
DiseaseDepression, Bipolar

CACNA1C CACNA1D SCN2A

3.24e-03791103C0005587
Diseaseepilepsy (implicated_via_orthology)

TRIO KALRN GRIN2B SCN2A

3.29e-031631104DOID:1826 (implicated_via_orthology)
DiseaseImmunologic Deficiency Syndromes

CACNA1C C3

3.31e-03231102C0021051

Protein segments in the cluster

PeptideGeneStartEntry
DAEEWALYLTEVFLH

BANK1

36

Q8NDB2
HADINLLYWSDEEAV

DNMT1

1036

P26358
EHYEKAENGDLNWII

CDC14B

206

O60729
LTDLHWDHDYLEGTD

SMPD1

206

P17405
YRNEKDSVDWHSDDE

ALKBH3

181

Q96Q83
EIASYLITFEKHDEW

CAMTA2

46

O94983
HYLDETEQWEKFGLE

C3

1026

P01024
KWGEEDFEDNRHLYR

DEPDC1B

91

Q8WUY9
HDLNEDGLVSWEEYK

CALU

116

O43852
INYDQDRDEHWVKDL

CEP170B

46

Q9Y4F5
EKHSESWELDEVNYA

CAPN11

541

Q9UMQ6
EDGYIDIWDLLEKTH

DNAI3

736

Q8IWG1
QEIYSSEWDGHEELK

BIN2

86

Q9UBW5
EHYEKAENGDLNWII

CDC14C

176

A4D256
AAHFDIDWGKEDDSN

CHD1

1246

O14646
SDDHYEREKREVDWN

DISP1

271

Q96F81
DTEYAEWLRNHFLAE

ATP10D

851

Q9P241
SVVKGDAEEIADHWY

CCDC60

441

Q8IWA6
DAEEIADHWYFDLLS

CCDC60

446

Q8IWA6
DRSFVWHALDYADEL

RANBP2

1261

P49792
RHYQETSEDWSDAKE

RBM44

776

Q6ZP01
DDTWDLVHQDGKEKY

IQCM

401

A0A1B0GVH7
YGDIHFDDDEKWTED

MMP10

191

P09238
EWLDFLEKFSEHYHS

MSH3

806

P20585
IHDYADWVKEASGDL

NUP98

1246

P52948
THESDDLRWEKYAGE

PRKD1

861

Q15139
DLEWYEKSEETHASQ

MAD2L1BP

16

Q15013
KLEDTENWLYEDGED

HSPA4

651

P34932
YDKQLDEREHTIEEW

MAPK10

376

P53779
DYNREEDAALFKAWA

IRF4

61

Q15306
EKFDADYTEFEHWLQ

DST

3926

Q03001
AEDAEVHAENWLRLY

MMP15

46

P51511
HVDFAQARDDLYEWE

ENOX2

201

Q16206
YGWDNLSDKAHVEDI

GPR137C

281

Q8N3F9
ESGFEHAWRELDKDA

ESF1

326

Q9H501
FWDKVLEEAEAQHLY

PARG

576

Q86W56
EYWDFDIFELEAATH

PDE8A

496

O60658
EFDGSLDYNHEEWIE

KALRN

171

O60229
DSEQAYERWKERLDH

KIAA0408

281

Q6ZU52
LTHLKEYWNDPELDE

KRI1

221

Q8N9T8
PAWEALAEKYQDHED

PDIA2

426

Q13087
EGRLEDQLDKYDHWA

TWNK

461

Q96RR1
DQLDKYDHWADRFED

TWNK

466

Q96RR1
HEAEEWYRSKFADLT

GFAP

251

P14136
SREDWLEAIEEHSAY

OSBPL1A

321

Q9BXW6
PDEKHWNDLALEFHY

DSTYK

686

Q6XUX3
WKEYLEFEIENGTHE

PRPF39

356

Q86UA1
YWDDISDSAKDFIRH

CAMK1

241

Q14012
DWDGVRKHLDEYASI

LPCAT2

356

Q7L5N7
EDENLPHYDEKTWFV

PIK3R3

346

Q92569
ARHAWLYQAEEEFEK

ESS2

176

Q96DF8
WYKDFVTDADAEVLE

ATRX

2001

P46100
HLDEFKRIWAEYDPE

CACNA1C

1541

Q13936
WEFERDDDEYIKFLD

CPLANE1

1541

Q9H799
PHHLDEFKAIWAEYD

CACNA1S

1396

Q13698
EKFEFWEDFEEDHGK

CHD2

666

O14647
YSDHDDRWETKEGAA

CCDC9

361

Q9Y3X0
EISKGYDTTEWHEDL

DNAH7

2366

Q8WXX0
FSGKAYADEERWDLD

CRIM1

821

Q9NZV1
FYEHAKALWEDEGVR

GNAS

146

P63092
KDPHAEEFEDKEWTF

EHBP1

86

Q8NDI1
WEAAHEAEQLRAYLD

HLA-A

171

P04439
KEDSEQWDSIYHALG

ENO4

446

A6NNW6
EEWEHLDSDQKLLYG

KRBOX5

16

Q7Z2F6
EHYLEDADWFLKADD

C1GALT1

156

Q9NS00
DADWFLKADDDTYVI

C1GALT1

161

Q9NS00
EAWHELAELYINEHD

EMC2

156

Q15006
AWLEHNQLAEKEEYE

HSPA6

581

P17066
EFYKSLTNDWEDHLA

HSP90AA1

311

P07900
YLVTAERVWSDDHKD

GJB5

36

O95377
VLDAQWLYDNHKDES

DKC1

266

O60832
HFYELVEDTKDGIWL

RNF103

106

O00237
GAAYKLDDWALHRED

INAVA

171

Q3KP66
HLDEFKRIWSEYDPE

CACNA1D

1481

Q01668
KGDVHNWKLTEEDYE

SLC7A3

211

Q8WY07
SWTEEEDRIIYEAHK

MYBL1

141

P10243
EWDLFHDELEDFYDL

MKRN1

466

Q9UHC7
GELEIQATWYEKLHE

MTOR

1441

P42345
KDIDSTDHDRWCEYI

CWH43

601

Q9H720
REGYAWAEDKEHCEE

RTCB

181

Q9Y3I0
LLKFEDEEAQAVYWH

TARS1

141

P26639
KRDDFFYEDRNHDDW

RBM7

231

Q9Y580
ALEKGDESADCHLWY

RMDN3

311

Q96TC7
YEHVKRDLNPEDFWE

SLK

21

Q9H2G2
WFKSSKAEDEYEHEV

FER1L5

1371

A0AVI2
KAEDEYEHEVDWWSK

FER1L5

1376

A0AVI2
KDEVAESTHYADLWL

NHS

936

Q6T4R5
WDCDQGKHSDSDYRE

SCHIP1

11

P0DPB3
DDKDDSVWFLDHDYL

PSMD7

61

P51665
DSELDEHIKWFQQEY

SAMD3

281

Q8N6K7
WAGAHEEVDYTEKLK

PRRC2A

326

P48634
EYADTDKWAAELSEL

STRIP1

71

Q5VSL9
YDEETTDLLAHWNEA

SSH1

361

Q8WYL5
DEYWSDSEHIFLDAN

TET1

1991

Q8NFU7
WDEDFADVYHDLIHS

C12orf4

121

Q9NQ89
LLLVAGYAHDDDWID

CLCC1

11

Q96S66
FIGWDLDLYHEESDQ

ATP11B

371

Q9Y2G3
SDHDKKYEEEQWEIR

RNF17

1371

Q9BXT8
GLRFDHDSWEEEYDE

PLEKHG5

291

O94827
YLHDDREGEGSDKWV

THRAP3

881

Q9Y2W1
ELIEKGHWDDVFLDS

RPAP3

396

Q9H6T3
DDFHWEEYLKETGSI

SCML2

31

Q9UQR0
QKGNDDHWIVDTDYD

RBP4

116

P02753
ELWLYEVEGHLASDD

SPTAN1

691

Q13813
VSIFNWDEYIEDKSH

SCN2A

311

Q99250
YSDLHELGELVFKDW

TTC41P

231

Q6P2S7
EWDLLDEAQKHLYFD

ZNF211

46

Q13398
GKDDQTDHWYKFDDG

USP9Y

1891

O00507
EETDHEHDVYWKSFN

ZNF286B

186

P0CG31
DDDECSAWLHKLYQE

AGPAT4

266

Q9NRZ5
FHDGDYLNDEALWNK

TM4SF4

131

P48230
EEEHLWECKQLGAYS

ZMYM4

1361

Q5VZL5
KHWNRFRDEVEDDYI

SPOCK2

56

Q92563
EFDGCLEYNHEEWIE

TRIO

201

O75962
DEDLHDILDYWKGVS

ELFN2

801

Q5R3F8
EYDLESIDWLHIEFT

MYO7A

476

Q13402
WYKDEREISVDEKHD

MYOM1

1391

P52179
WEHVDLTDIYKERSD

GRIN2B

1146

Q13224